Breastfeeding Mothers Taking Martek's DHA Results in Better Sustained Attention in Children
Data Presented at Pediatric Academic Societies' Meeting
COLUMBIA, Md., May 4 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation (Nasdaq: MATK) announced today that a study presented at the Pediatric Academic Societies' Annual Meeting in San Francisco, California, showed that five-year-old children whose mothers received a 200mg dose of Martek's docosahexaenoic acid (DHA) for the first 4 months of breastfeeding performed better on a test of sustained attention than those whose mothers received a placebo. DHA is an essential fatty acid naturally present in breast milk, and a key building block of the developing infant's brain and
visual system. American women's breast milk levels of DHA are among the lowest in the world because of low DHA intake in the diet. Supplementation of DHA during breastfeeding elevates these levels...."